Klaus-Jürgen Gutleben

Risk for ventricular fibrillation in peripartum cardiomyopathy with severely reduced left ventricular function—value of the wearable cardioverter/defibrillator

The true incidence of life‐threatening ventricular tachyarrhythmic events and the risk of sudden cardiac death in the early stage of peripartum cardiomyopathy (PPCM) are still unknown. We aimed to assess the usefulness of the wearable cardioverter/defibrillator (WCD) to bridge a potential risk for life‐threatening arrhythmic events in patients with early PPCM, severely reduced left ventricular ejection fraction (LVEF) and symptoms of heart failure.

Treatment of Cheyne-Stokes Respiration Reduces Arrhythmic Events in Chronic Heart Failure

This study aimed to investigate whether adequate treatment of Cheyne‐Stokes respiration (CSR) reduces the risk of arrhythmic events in patients with chronic heart failure (CHF).

Cryoballoon Pulmonary Vein Isolation Supported by Intracardiac Echocardiography: Integration of a Nonfluoroscopic Imaging Technique in Atrial Fibrillation Ablation

Intracardiac Echo Supported Cryoballoon Ablation. Introduction: Cryoballoon ablation has been adopted for pulmonary vein (PV) isolation (PVI) in many centers. Complete occlusion of PV by an adequately sized balloon is crucial for effectiveness of cryoenergy delivery. The aim of this study was to evaluate intracardiac echocardiography (ICE) as an alternative imaging technique compared to angiographic imaging in cryoballoon PVI.

Intracardiac echocardiography for registration of rotational angiography-based left atrial reconstructions: a novel approach integrating two intraprocedural three-dimensional imaging techniques in atrial fibrillation ablation

AIMS Image integration of three-dimensional (3D) reconstructions of left atrial (LA) and pulmonary vein (PV) anatomy into electroanatomical mapping (EAM) plays a major role in atrial fibrillation (AF) ablation. Point-by-point EAM is commonly used for registration of imported LA and PV anatomy. We aimed to assess the accuracy of intraprocedural rotational angiography-based LA imaging registered by spatial reconstruction of intracardiac echocardiography (ICE) in patients undergoing AF ablation. METHODS AND RESULTS Twenty-two patients (11 males, 66 ± 12 years) were studied. Reconstructions of LA and PVs based on rotational angiography were registered by a second 3D reconstruction based on ICE. In a second step, EAM points were added to ICE 3D reconstructions. A 3D image of the LA and PVs was reconstructed in all patients by both imaging modalities. Rotational angiography and ICE-based LA 3D reconstructions took 11.5 ± 5.2 and 20.4 ± 11.2 min, respectively. A total of 17 ± 6 two-dimensional ICE fans were used for spatial reconstruction of ICE. The deviation between the two 3D shells was 2.6 ± 0.5 mm. Integration of 78 ± 58 EAM points into ICE 3D reconstruction did not significantly reduce the deviation to rotational angiography-based reconstructions (2.7 ± 0.6 mm). All PVs were isolated successfully. CONCLUSIONS Intraprocedural 3D reconstruction of LA and PVs for ablation of AF is feasible based on both rotational angiography and ICE. LA reconstructions based on rotational angiography can accurately be registered using 3D ICE shells. Additional EAM does not enhance accuracy. Therefore, registration of rotational angiography-based 3D reconstructions by 3D reconstructions from ICE seems to be an alternative technique to support AF ablation.

Additional electrodes on the Quartet™ LV lead provide more programmable pacing options than bipolar and tripolar equivalents

Aims The aim of this study was to evaluate any benefits to the number of viable pacing vectors and maximal spatial coverage with quadripolar left ventricular (LV) leads when compared with tripolar and bipolar equivalents in patients receiving cardiac resynchronization therapy (CRT). Methods and Results A meta-analysis of five previously published clinical trials involving the Quartet™ LV lead (St Jude Medical, St Paul, MN, USA) was performed to evaluate the number of viable pacing vectors defined as capture thresholds ≤2.5 V and no phrenic nerve stimulation and maximal spatial coverage of viable vectors in CRT patients at pre-discharge (n = 370) and first follow-up (n = 355). Bipolar and tripolar lead configurations were modelled by systematic elimination of two and one electrode(s), respectively, from the Quartet lead. The Quartet lead with its four pacing electrodes exhibited the greatest number of pacing vectors per patient when compared with the best bipolar and the best tripolar modelled equivalents. Similarly, the Quartet lead provided the highest spatial coverage in terms of the distance between two furthest viable pacing cathodes when compared with the best bipolar and the best tripolar configurations (P < 0.05). Among the three modelled bipolar configurations, the lead configuration with the two most distal electrodes resulted in the highest number of viable pacing vectors. Among the four modelled tripolar configurations, elimination of the second proximal electrode (M3) resulted in the highest number of viable pacing options per patient. There were no significant differences observed between pre-discharge and first follow-up analyses. Conclusion The Quartet lead with its four electrodes and the capability to pace from four anatomical locations provided the highest number of viable pacing vectors at pre-discharge and first follow-up visits, providing more flexibility in device programming and enabling continuation of CRT in more patients when compared with bipolar and tripolar equivalents.

Reliability and accuracy of sleep apnea scans in novel cardiac resynchronization therapy devices: an independent report of two cases

Pacemaker apnea scan algorithms are able to screen for sleep apnea. We investigated whether these systems were able to accurately detect sleep-disordered breathing (SDB) in two patients from an outpatient clinic. The first patient suffered from ischemic heart failure and severe central sleep apnea (CSA) and underwent adaptive servoventilation therapy (ASV). The second patient suffered from dilated cardiomyopathy and moderate obstructive sleep apnea (OSA). Pacemaker read-outs did not match polysomnography (PSG) recordings well and overestimated the apnea–hypopnea index. However, ASV therapy-induced SDB improvements were adequately recognized by the apnea scan of the Boston Scientific INVIVE® cardiac resynchronization therapy pacemaker. Detection of obstructive respiratory events using impedance-based technology may underestimate the number of events, as frustrane breathing efforts induce impedance changes without significant airflow. By contrast, in the second case, apnea scan overestimated the number of total events and of obstructive events, perhaps owing to a very sensitive but less specific hypopnea definition and detection within the diagnostic algorithm of the device. These two cases show that a pacemaker apnea scan is able to reflect SDB, but PSG precision is not met by far. The device scan revealed the decline of SDB through ASV therapy for CSA in one patient, but not for OSA in the second case. To achieve reliable monitoring of SDB, further technical developments and clinical studies are necessary.ZusammenfassungSchrittmacher-Apnoescan-Algorithmen können zum Apnoe-Screening genutzt werden. Wir untersuchten, ob diese Systeme zuverlässig für die Erkennung schlafbezogener Atemstörungen sind bei 2 Patienten unserer Ambulanz. Der erste Patient hatte eine ischämische Kardiomyopathie, schwere zentrale Schlafapnoe (ZSA) und erhielt eine adaptive Servoventilationstherapie (ASV). Der zweite Patient hatte eine dilatative Kardiomyopathie und ein mittelgradiges obstruktives Schlafapnoe-Syndrom (OSAS). Die Schrittmacher-Ausdrucke korrelierten nicht gut mit der Polysomnographie (PSG) und überschätzten den Apnoe-Hypopnoe-Index (AHI). ASV-Therapie-induzierte Verbesserungen der Schlafapnoe wurden jedoch adäquat durch den Apnoe-Scan des CRT-Schrittmachers erkannt. Die Anzahl obstruktiver Atemereignisse kann durch Impedanz-messende Algorithmen unterschätzt werden, da frustrane Atemmanöver Impedanzänderungen verursachen ohne signifikanten Luftstrom. Auf der anderen Seite zeigt der 2. Fall, dass der Apnoe-Scan die Anzahl aller Ereignisse und aller obstruktiven Ereignisse überschätzen kann, am ehesten aufgrund einer zu sensitiven und zu unspezifischen Definition der Hypopnoe und -Detektion in diesem diagnostischen Device-Algorithmus. Diese 2 Fälle zeigen, dass Schrittmacher Apnoe-Scans in der Lage sind, schlafbezogene Atemstörungen zu erkennen, jedoch mit einer Präzision weit unter der Polysomnographie. Der Device-Scan erkannte die Abnahme der Schlafapnoe durch ASV-Therapie bei ZSA bei einem Patienten, jedoch nicht für OSAS im zweiten Fall. Um Schlafapnoe zuverlässig monitoren zu können, sind weitere technische Verbesserungen und klinische Studien notwendig.

Cardiac or Other Implantable Electronic Devices and Sleep-disordered Breathing - Implications for Diagnosis and Therapy.

Sleep-disordered breathing (SDB) is of growing interest in cardiology because SDB is a highly prevalent comorbidity in patients with a variety of cardiovascular diseases. The prevalence of SDB is particularly high in patients with cardiac dysrhythmias and/or heart failure. In this setting, many patients now have implantable cardiac devices, such as pacemakers, implantable cardioverter-defibrillators or implanted cardiac resynchronisation therapy devices (CRT). Treatment of SDB using implantable cardiac devices has been studied previously, with atrial pacing and CRT being shown not to bring about satisfactory results in SDB care. The latest generations of these devices have the capacity to determine transthoracic impedance, to detect and quantify breathing efforts and to identify SDB. The capability of implantable cardiac devices to detect SDB is of potential importance for patients with cardiovascular disease, allowing screening for SDB, monitoring of the course of SDB in relation to cardiac status, and documenting of the effects of treatment.

Rescue-stenting of an occluded lateral coronary sinus branch for recanalization after dissection during cardiac resynchronization device implantation

Cardiac resynchronization therapy (CRT) using left- (LV) or biventricular pacing is widely applied in selected heart failure patients. However, transvenous LV-lead placement into coronary sinus (CS) branches can be challenging. A 77-year-old female patient with New York Heart Association class III symptoms due to dilated cardiomyopathy [LV ejection fraction (LVEF): 10%, QRS-duration: 150 ms], despite optimal medical treatment presented for CRT. Coronary sinus angiograms were performed after transvenous CS cannulation. Within a large posterolateral vein, low phrenic nerve stimulation thresholds were found. The only alternative smaller tortuous lateral branch showed a significant narrowing, making LV-lead advancement impossible. Angioplasty was performed, using a venoplasty balloon. This caused complete branch occlusion. After recanalization of the vessel by implantation of a bare metal stent, the lead could be advanced through the stent. Optimal pacing parameters without phrenic nerve stimulation were established. Angioplasty of CS branches during CRT implantation procedures bears the risk of complete branch occlusion, but recanalization can acutely be achieved by stent implantation. This is the first report on rescue-stenting of a CS branch after angioplasty-related occlusion. Transthoracic lead implantation, accompanied risks, and slower recovery could thus be avoided.

Detection and therapy of respiratory dysfunction by implantable (cardiac) devices

Sleep-disordered breathing (SDB) represents a common comorbidity in cardiac patients. The prevalence of obstructive sleep apnea (OSA) and central sleep apnea (CSA) is very high, particularly in patients with heart rhythm disorders and heart failure (HF). Patients with pacemakers (PM) and implantable defibrillators (ICD) including cardiac resynchronization therapy (CRT) show SDB prevalences up to 75%. However, some modern PM, ICD and CRT devices allow the detection of SDB via transthoracic impedance analysis with high sensitivity compared to polysomnographic (PSG) controls. Thus, this method could be of relevance in screening and monitoring SDB in patients with implantable cardiac devices. Preliminary studies demonstrated the possibility to treat OSA in selected patients by stimulation of the cranial nerves, especially the hypoglossal nerve. However, this requires extensive diagnostics and advanced surgical approaches including many medical disciplines and is not part of this review article. However, unilateral and transvenous stimulation of the phrenic nerve to treat central sleep apnea and Cheyne-Stokes respiration in HF patients in particular can be performed by cardiologists. This article summarizes preliminary data on the results of this promising therapy.

Long‐Term Experience with First‐Generation Implantable Neurostimulation Device in Central Sleep Apnea Treatment

Sleep‐disordered breathing (SDB) and Cheyne‐Stokes respiration (CSR) are associated with shorter survival in patients with heart failure. A novel treatment method for this patient group is unilateral phrenic nerve stimulation by the remedē® system (Respicardia Inc., Minnetonka, MN, USA), a transvenously implantable neurostimulation device, which has recently been studied in a large randomized, controlled trial. Previous literature has shown efficacy and safety of the treatment with this first‐generation device, but hardly any data are available on long‐term clinical parameters, the remedē® devices battery lifetime, device exchangeability, lead position stability, surgical accessibility, and manageability.